Sail Biomedicines
PrivateLast Round
Strategic
Jul 29, 2026
Total Funding Raised
$610.44M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sail Biomedicines is a biotechnology company that develops a programmable medicine platform combining circular RNA technology and targeted nanoparticles with artificial intelligence to design and deploy medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sail Biomedicines Comparables
Compare Sail Biomedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Circurna | 84% | |
| AbbVie | 84% | |
| RiboX Therapeutics | 84% |
Sail Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 29, 2026 | ||||
| Grant | Dec 1, 2023 | ||||
| Grant | Dec 1, 2023 | ||||
| Series A | May 10, 2021 | ||||
| Series A | Oct 28, 2020 |
Sail Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bill & Melinda Gates Foundation | Grant |
| Johnson & Johnson Innovation – JJDC | Strategic |
| Flagship Pioneering | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 32% MoM.
- Jul 29, 2026
$465M round led by Johnson & Johnson Innovation – JJDC.
Recent news
Latest coverage and updates
- receives_financingAug 19, 2026
Sail Biomedicines, Inc. received financing of $140M on Aug 19th '26.
- is_developingJul 31, 2026
Sail Biomedicines, Inc. is planning to develop pipeline of in vivo CAR-T based products.
- partners_withJul 31, 2026
Sail Biomedicines, Inc. partnered with Johnson & Johnson Co. on Jul 29th '26.
- receives_financingJul 30, 2026
Sail Biomedicines, Inc. was planning to receive financing of $465M in equity investment on Jul 29th '26.
- is_developingJul 29, 2026
Sail Biomedicines, Inc. is developing class of RNA medicines on Jul 1st '26.
Sail Biomedicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sail Biomedicines's valuation, stock price, and market status.
Is Sail Biomedicines a public or private company?
Sail Biomedicines is a private company.
What is the current stock price of Sail Biomedicines?
Sail Biomedicines is a private company with no public stock price. No recent secondary market data is available.
How much is Sail Biomedicines worth (valuation)?
Valuation information for Sail Biomedicines is not publicly available.
Can I buy Sail Biomedicines stock?
Sail Biomedicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sail Biomedicines's last funding round?
Sail Biomedicines's most recent funding round was Grant on December 1, 2023.
Who are the main investors in Sail Biomedicines?
Key investors in Sail Biomedicines include Bill & Melinda Gates Foundation, Flagship Pioneering.
Will Sail Biomedicines IPO soon?
No public IPO plans have been announced for Sail Biomedicines.
How can I track Sail Biomedicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sail Biomedicines's secondary market activity and sign up for updates.